UBE2CP3 and hepatocellular carcinoma: Moreover, Kaplan-Meier and log-rank test analysis suggested that HCC patients with high levels of lncRNA UBE2CP3 exhibited a reduced overall survival (OS) (P < 0.001; Figure 1E).